Welcome to LookChem.com Sign In|Join Free

CAS

  • or

400860-13-1

Post Buying Request

400860-13-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

400860-13-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 400860-13-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,0,8,6 and 0 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 400860-13:
(8*4)+(7*0)+(6*0)+(5*8)+(4*6)+(3*0)+(2*1)+(1*3)=101
101 % 10 = 1
So 400860-13-1 is a valid CAS Registry Number.

400860-13-1Relevant articles and documents

Carbonic anhydrase activators: High affinity isozymes I, II, and IV activators, incorporating a β-alanyl-histidine scaffold

Scozzafava, Andrea,Supuran, Claudiu T.

, p. 284 - 291 (2007/10/03)

A novel class of tight binding carbonic anhydrase (CA) activators was designed by using histamine and histidine as lead molecules. Carnosine (β-Ala-His) derivatives were synthesized by reaction of appropriately derivatized β-alanines with imidazole/carboxy-protected histidine in the presence of carbodiimides, followed by removal of the various protecting groups. The derivatized β-alanines mentioned above were in turn obtained by coupling of 4-fluorophenyl-sulfonylureido amino acids (fpu-AA) or 2-toluenesulfonylureido amino acids (ots-AA) with β-Ala. Some structurally related dipeptides with the general formula fpu/ots-AA1-AA2 (AA, AA1, and AA2 represent amino acyl moieties) were also prepared by a similar strategy and used thereafter for obtaining CA activators incorporating a modified tetrapeptide scaffold. Many of the new tri-/tetrapeptide derivatives reported here proved to be efficient in vitro activators of three CA isozymes. Very good activity was detected against hCA I and bCA IV, for which some of the new compounds showed affinities in the 1-20 nM range (h = human; b = bovine isozymes), whereas against hCA II, their affinities were in the range of 10-40 nM. Ex vivo experiments showed some of the new activators to strongly enhance cytosolic red cell CA activity after incubation with human erythrocytes. This new class of CA activators might lead to the development of drugs/diagnostic tools for the management of CA deficiency syndromes, as well as for the pharmacological enhancement of synaptic efficacy, spatial learning, and memory. This may constitute a new approach for the treatment of Alzheimer's disease and other conditions in need of achieving memory therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 400860-13-1